xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

634

International consensus statement on rhinosinusitis

(Continues)

Rate of major complications for primary ESS – 0.36%; revision ESS – 0.46% Age > 40, Medicaid, frontal sinus work,

Henriquez 2210 2013 2 Prospective, Pts with synechiae had significantly less improvement on RSDI total scores and less on CSS scores Asaka 100 2012 2 Prospective cohort study 706CRSpt Evaluate complications of ESS and identify patient risk factors Berlucchi 2190 2009 2 Multicenter, blinded prospective randomized 66 patients with CRS Evaluate efficacy of multi-institutional cohort 286 CRS patients Evaluate impact of synechiae formation on HRQoL outcomes

Risk factors: asthma and polyp scores Lower proportion of adhesions in MeroGel group at 4 and 12 weeks post op

No significant difference in blood loss or surgical conditions

Major complication rate 1% (0.17% CSF leak, 0.07% orbital injury, 0.76% hemorrhage)

Heaton 2277 2012 3 Retrospective Pts with CSF leak had greater angle of skull base in sagittal plane and slope in coronal as well as higher Keros score Ramakrishnan 2150 2012 3 Retrospective review 62,823 pts undergoing ESS Determine nationwide incidence of major complications in ESS case-control 18 CRS pts with CSF leak afterESS 18 CRS pts without CSF leak after ESS Compare preoperative sinus imaging of ESS pts with and without CSF leak

Overall complication rate 0.50% Revision surgery not associated with increased rates of CSF leak,

hemorrhage, toxic shock syndrome; there was a higher rate of orbital injury

5.8% perioperative complications (5.7% minor, 0.1% major)

and IGS use were factors at higher risk for complications

Study Year LOE Study Design Study Groups Clinical Endpoint Conclusions

MeroGel (absorbable packing at reducing postop adhesions

Compare blood loss during ESS under

TIVA with propofol vs inhalational anesthesia (sevoflurane)

Determine incidence of major complications

following primary and revision ESS

Suzuki 101 2015 2 Retrospective cohort study 50,734 CRS pts Evaluate complication rates associated with

different types of ESS

undergoing ESS

78,944 CRS patients undergoing ESS

33 CRSs/wNP

Krings 98 2014 3 Retrospective cohort analysis

controlled trial

Chaaban 1839 2013 3 Prospective, randomized controlled trial

TABLE XII-27 (Continued)